

Examination of Clinical Trial Costs and Barriers for Drug Development. E.3 Barriers to Clinical Trials
The major obstacles to conducting clinical trials in the United States identified through this research include: high financial cost, the lengthy time frames, difficulties in recruitment and retention of participants, insufficiencies in the clinical research workforce, drug sponsor-imposed barriers; regulatory and administrative barriers, the disc